In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Long term treatment: the importance of getting it right first time!
Session

Event : Acute Cardiovascular Care 2019

Topic : Acute Coronary Syndromes – Treatment

  • Session type : Meet the Experts
  • Date : 03 March 2019
  • Time : 11:00 - 12:30

6 presentations in this session

Long term treatment: the importance of getting it right first time! - Panel discussion and questions from the audience.

Event : Acute Cardiovascular Care 2019

  • Session : Long term treatment: the importance of getting it right first time!

Introduction to the session.

Event : Acute Cardiovascular Care 2019

  • Session : Long term treatment: the importance of getting it right first time!
  • Speaker : D Zahger (Beer Sheva,IL)

Case 1: A patient with severe hypercholesterolemia.

Event : Acute Cardiovascular Care 2019

  • Session : Long term treatment: the importance of getting it right first time!
  • Speaker : KA Krychtiuk (Vienna,AT)

Case 2: A patient with symptomatic PAD and chronic kidney disease.

Event : Acute Cardiovascular Care 2019

  • Session : Long term treatment: the importance of getting it right first time!
  • Speaker : M Schoos (Klampenborg,DK)

Case 3: A metabolic nightmare – an obese ACS patient with diabetes and high triglycerides.

Event : Acute Cardiovascular Care 2019

  • Session : Long term treatment: the importance of getting it right first time!
  • Speaker : PP Buszman (Katowice,PL)

High-risk ACS patient: select early the long-term treatment! - Take home message.

Event : Acute Cardiovascular Care 2019

  • Session : Long term treatment: the importance of getting it right first time!
  • Speaker : S Halvorsen (Oslo,NO)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are